RoboCT

Hangzhou RoboCT Technology Development Co., Ltd. was established in January 2017 as a technology enterprise integrating research, production, and sales. The company's predecessor was Harbin RoboCT Technology Development Co., Ltd. (2012), and it is currently divided into the Hangzhou headquarters and the Harbin branch. RoboCT focuses on the development of exoskeleton robot technology, intelligent medical devices, special robot technology, and intelligent systems. Its Harbin branch was recognized as a National High-tech Enterprise in 2015. After years of technical accumulation, RoboCT has successfully completed numerous scientific research and industrial product projects, applied for more than 100 independent intellectual property rights, and won over 20 awards in various fields. It is a robotics technology company driven by technological innovation.RoboCT is committed to providing intelligent rehabilitation equipment, rehabilitation aids, and intelligent solutions for individuals with mobility impairments, the elderly, and rehabilitation medical institutions through artificial intelligence (AI), robotics technology, data analysis, and cloud computing, promoting the development of medical rehabilitation and elderly care industries. Its mission is to benefit patients with physical disabilities and those with limited mobility. At the same time, it also engages in the research and product development of exoskeleton technology in fields such as entertainment, industry, and sports. In 2018, RoboCT secured Pre-A round financing, bringing in industrial investors. The injection of capital and resources further accelerated RoboCT’s development. All employees of RoboCT uphold the corporate culture of "problem-solving, mutual trust, and keeping pace with the times" to expand human perception and physical capabilities, meeting people's core needs for convenient mobility and free living. They remain true to the corporate mission, keep their technology and vision up-to-date, maintain technological advancement, and provide better robotic products. By focusing on precision work in intelligent technology, they enhance the safety and advancement of products through technology and improve user experience through humanistic care. They continuously refine the exoskeleton technology industry chain to become a global leader in the exoskeleton field. The era of artificial intelligence has arrived, and the future will inevitably be an era of human-machine integration. Exoskeletons will inevitably become another附属 organ for humans. A small step for RoboCT's exoskeleton is a giant leap for humanity.